StockData
Ascend Wellness Holdings, Inc. logo

Ascend Wellness Holdings, Inc. (AAWH) stock

AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.39−0.00 (-0.73%)

Close on Oct 19, 2026Market cap $79.60MP/E –Yield –

Ascend Wellness ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Ascend Wellness's ebitda for the twelve months ending Jun 30, 2026 was $48.52M, down 17.8% year over year. For fiscal 2025 it was $56.52M, down 20.3% from the year before. The highest annual figure on record is $70.89M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.52M-20.3%
FY2024Dec 31, 2024$70.89M+28.0%
FY2023Dec 31, 2023$55.36M+87.2%
FY2022Dec 31, 2022$29.58M+489.8%
FY2021Dec 31, 2021$5.02M-75.4%
FY2020Dec 31, 2020$20.41M–
FY2019Dec 31, 2019-$22.02M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.81M+91.8%
Q1 FY2026Mar 31, 2026$20.83M-0.3%
Q4 FY2025Dec 31, 2025$3.36M-85.8%
Q3 FY2025Sep 30, 2025$8.52M+34.2%
Q2 FY2025Jun 30, 2025$8.25M+16.9%
Q1 FY2025Mar 31, 2025$20.89M+10.2%
Q4 FY2024Dec 31, 2024$23.57M+53.5%
Q3 FY2024Sep 30, 2024$6.35M-42.5%
Q2 FY2024Jun 30, 2024$7.05M–
Q1 FY2024Mar 31, 2024$18.96M-14.6%
Q4 FY2023Dec 31, 2023$15.36M-7.9%
Q3 FY2023Sep 30, 2023$11.04M+92.1%
Q2 FY2023Jun 30, 2023-$945.00K-138.5%
Q1 FY2023Mar 31, 2023$22.20M–
Q4 FY2022Dec 31, 2022$16.66M+247.5%
Q3 FY2022Sep 30, 2022$5.75M-59.3%
Q2 FY2022Jun 30, 2022$2.45M-61.5%
Q1 FY2022Mar 31, 2022-$4.86M–
Q4 FY2021Dec 31, 2021$4.80M-30.7%
Q3 FY2021Sep 30, 2021$14.13M+150.1%
Q2 FY2021Jun 30, 2021$6.37M+52.8%
Q1 FY2021Mar 31, 2021-$25.74M-1812.3%
Q4 FY2020Dec 31, 2020$6.93M–
Q3 FY2020Sep 30, 2020$5.65M–
Q2 FY2020Jun 30, 2020$4.17M–
Q1 FY2020Mar 31, 2020$1.50M–

More Ascend Wellness figures

See a number that looks wrong?